Blue Hope Research Award
At the Colon Cancer Alliance, we know a proactive approach is vital to knocking colon cancer out of the top three cancer killers. Scientific research is among the best ways we can go on the offensive against this disease. That’s why we’ve launched the Blue Hope Research Award. The specific focus of this award will change year-to-year as new advancements and needs are uncovered in the world of colon cancer research.
WHAT WE’VE DONE
In 2014, we utilized the American Association for Cancer Research peer-review process to select a scientist who is taking a deeper look at biomarkers associated with treatment of colon cancer. Biomarkers are a key to unlocking personalized care in order to provide treatments with a higher likelihood of effectiveness. This one-year fellowship provides vital resources and funding to a bright investigator interested in making his mark in the colon cancer space.
We’re excited to announce that we’ve awarded our second Blue Hope Research Award to Kent W. Mouw, M.D., Ph.D. Dr. Mouw, who is currently a resident at the Dana-Farber Cancer Institute, will be studying a newly discovered genetic mutation that is found in colon cancer patients diagnosed under the age of 50.
“I am honored to be affiliated with Colon Cancer Alliance and to have this opportunity to work with other scientists, clinicians and activists in striving to improve outcomes for colorectal cancer patients. I am immensely thankful for the support of organizations such as the Colon Cancer Alliance that generously donate their time and resources to fund the work of young scientists like myself.” - Dr. Mouw
We're honored to introduce Marios Giannankis, M.D., Ph.D., as our first-ever Blue Hope Research Award recipient. Dr. Giannakis is a Medical Oncology Fellow at the Dana-Farber Cancer Institute (DFCI) and also performs colon cancer research at the Broad Institute of MIT and Harvard.
“There has not been a more exciting time in cancer research in terms of what we can understand about tumors and their biology. I love what I do because I believe the colorectal cancer research we are performing at the DFCI and Broad Institute has the potential to help create better therapies, supporting those affected by cancer. I cannot think of a better accomplishment than having the privilege of taking care of people with cancer and being successful in research to better fight this disease.” – Dr. Giannakis
Every year, 15,000 people under age 50 are diagnosed with colon cancer. What’s even more concerning is that this number is on the rise, even though rates for those over 50 continue to decline.
We know that screening is less common in younger individuals, and key symptoms are often unrecognized and misdiagnosed. But there is still much more to learn about why this is happening and how we can go on the offensive. The more we learn, the closer we are to getting ahead of these trends and providing younger individuals with the tools they need to take control of their health. This year we will again utilize the AACR peer review process to evaluate the most promising research projects addressing this unique issue.
We would like to extend a very special thank you to Lauren Barnard, Erica Andracchio and the team at Roanne’s Race as well as the family and friends of Jake Lyons and Olympus for their generous gifts that will support our upcoming research grant on young-onset colon cancer. Thank you also to Brian and Kathleen Hersey, Christi Edwards and Joseph Gouveia for their support of this important research initiative.
Research is essential to moving the dial forward in the area of public health. It forms the foundation of program development and policies that will save lives. We’re committed to this effort and hope you’ll join us.
HOW YOU CAN HELP
We’re looking for sponsors to support critical research initiatives. To learn more, please contact Nicole Sheahan, Vice President of Development, at (202) 628-0123 ext. 103 or email@example.com.